Psychology & Psychiatry

Data on depression suggest possibility of personalized treatments

Depression is a complex disorder, characterized by clusters of symptoms that respond to treatment with varying degrees of success and are likely to reoccur after initial remission. However, a group of Yale researchers, combing ...

Medications

Aristada approved for schizophrenia

(HealthDay)—Aristada (aripiprazole lauroxil) extended release injection has been approved by the U.S. Food and Drug Administration to treat the disabling brain disorder schizophrenia, the agency said Tuesday in a news release.

Cardiology

Nationwide study examines common heart procedures

(HealthDay)—Risk factors for heart disease—such as being overweight, having high cholesterol levels and smoking—are common in patients who undergo angioplasty and stent procedures to open blocked coronary arteries, ...

Neuroscience

Researchers identify new drug target for schizophrenia

(Medical Xpress) -- Researchers at Mount Sinai School of Medicine may have discovered why certain drugs to treat schizophrenia are ineffective in some patients. Published online in Nature Neuroscience, the research will pave ...